Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
ACELRX PHARMA
(NQ:
ACRX
)
6.460
USD
UNCHANGED
Official Closing Price
/ Updated:
8:10 PM EDT, May 20, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
All news about ACELRX PHARMA
< Previous
1
2
3
4
Next >
AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA System and Plans to Hold a Conference Call and Webcast Tomorrow to Discuss Top-L
November 14, 2012
from
PR Newswire
AcelRx Pharmaceuticals (ACRX) Reports In-Line Q3 Loss of 38c/Share
November 06, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7849761 for the full story.
Read More
from
StreetInsider.com News Articles
AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
November 06, 2012
from
PR Newswire
Tuesday's Market Factors
November 06, 2012
category
Market/Outlook
,
Market/Outlook/2012/Q4
from
Wall Street Greek
Trading Radar for 11/06: AOL (AOL), Office Depot (ODP), Curtiss-Wright (CW),U.S. Auto Parts (PRTS), VIVUS (VVUS) Report
November 05, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7846327 for the full story.
Read More
from
StreetInsider.com News Articles
AcelRx Pharma (ACRX) Commences Dosing in NanoTab Phase 2
November 05, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7842701 for the full story.
Read More
from
StreetInsider.com News Articles
AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
November 05, 2012
- Phase 2 placebo-controlled, dose-finding study funded by a grant from the Department of Defense -
Read More
from
PR Newswire
AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
November 01, 2012
from
PR Newswire
Canaccord Genuity Assumes AcelRx Pharmaceuticals (ACRX) at Buy, Catalyst-Heavy
October 10, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7783668 for the full story.
Read More
from
StreetInsider.com News Articles
AcelRx Receives Notice of Eligibility for Centralized Review from European Medicines Agency for the Sufentanil NanoTab® PCA System
October 03, 2012
Centralized review process used for products that provide a significant therapeutic, scientific or technical innovation to patient health
Read More
from
PR Newswire
Guggenheim Starts AcelRx Pharmaceuticals (ACRX) at Buy
September 18, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7733976 for the full story.
Read More
from
StreetInsider.com News Articles
AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
September 18, 2012
from
PR Newswire
AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
September 10, 2012
from
PR Newswire
AcelRx (ACRX) Gets Additional Patents for Oral Transmucosal Admin of Sufentanil
August 29, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7691743 for the full story.
Read More
from
StreetInsider.com News Articles
AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
August 29, 2012
Two more U.S. patents expand intellectual property protection for AcelRx's pipeline of sufentanil NanoTab® pain products
Read More
from
PR Newswire
AcelRx Pharma (ACRX) Initiates ARX-01 Phase 3s
August 23, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7681169 for the full story.
Read More
from
StreetInsider.com News Articles
AcelRx Pharmaceuticals Initiates Third Phase 3 Clinical Trial for ARX-01, the Sufentanil NanoTab® PCA System, for the Treatment of Post-Operative Pain
August 23, 2012
First orthopedic surgery patient dosed in randomized, double-blind, placebo-controlled trial
Read More
from
PR Newswire
AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
August 23, 2012
from
PR Newswire
AcelRx (ACRX) Files $50M Mixed Shelf
August 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7652214 for the full story.
Read More
from
StreetInsider.com News Articles
AcelRx Pharmaceuticals (ACRX) Posts Q2 Loss of 35c/Share
August 09, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7647544 for the full story.
Read More
from
StreetInsider.com News Articles
AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
August 09, 2012
from
PR Newswire
AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
August 08, 2012
from
PR Newswire
AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
August 07, 2012
from
PR Newswire
AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
August 01, 2012
Two new U.S. patents expand intellectual property protection for AcelRx pipeline of sufentanil NanoTab® pain products
Read More
from
PR Newswire
NYSE, NASDAQ and OTC Companies Webcast Live to Online Investors, August 2nd, at RetailInvestorConferences.com
July 30, 2012
CEOs to take questions in real-time during formal roadshow presentations, meet and "chat" in virtual trade booths
Read More
from
PR Newswire
AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
July 20, 2012
Company invites individual and institutional investors to log-on to view July 12th presentation
Read More
from
PR Newswire
AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
July 10, 2012
Company invites Main Street and Wall Street investors to attend interactive real-time virtual conference
Read More
from
PR Newswire
OTC and NASDAQ-listed Companies Join to Webcast Live on July 12th at RetailInvestorConferences.com
July 10, 2012
CEOs to take questions in real-time during formal roadshow presentations, meet and "chat" in virtual trade booths
Read More
from
PR Newswire
Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com
July 09, 2012
CEOs to take questions in real-time during formal roadshow presentations, meet and "chat" in virtual trade booths
Read More
from
PR Newswire
AcelRx Pharmaceuticals to Present at the JMP Securities Healthcare Conference 2012
June 28, 2012
from
PR Newswire
< Previous
1
2
3
4
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here